Emilio Cordova
Vorstandsvorsitzender bei SAMDI Tech, Inc.
Aktive Positionen von Emilio Cordova
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
SAMDI Tech, Inc.
 SAMDI Tech, Inc. BiotechnologyHealth Technology Part of Charles River Laboratories International, Inc., SAMDI Tech, Inc. delivers better, faster assay development, high-throughput screening and hit-to-lead solutions for early-stage drug discovery. The company is based in Chicago, IL. Our highly skilled team of biochemistry experts believes in quality results and uses proprietary industry-leading, label-free SAMDI (Self-Assembled Monolayer Desorption Ionization) technology to deliver decision-making data for diverse targets and analytes. SAMDI Tech offers label-free drug discovery solutions for better, faster results. The company was founded by Michael Scholle, Milan Mrksich. Emilio Cordova has been the CEO of the company since 2015. SAMDI Tech was acquired by Charles River Laboratories International, Inc. on January 30, 2023 for $50 million. | Vorstandsvorsitzender | 01.01.2015 | - |
Karriereverlauf von Emilio Cordova
Ehemalige bekannte Positionen von Emilio Cordova
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
| INOTIV, INC. | Corporate Officer/Principal | - | 01.10.2008 |
Statistik
International
| Vereinigte Staaten | 3 |
Operativ
| Corporate Officer/Principal | 1 |
| Chief Executive Officer | 1 |
Sektoral
| Commercial Services | 2 |
| Health Technology | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| INOTIV, INC. | Commercial Services |
| Private Unternehmen | 1 |
|---|---|
SAMDI Tech, Inc.
SAMDI Tech, Inc. BiotechnologyHealth Technology Part of Charles River Laboratories International, Inc., SAMDI Tech, Inc. delivers better, faster assay development, high-throughput screening and hit-to-lead solutions for early-stage drug discovery. The company is based in Chicago, IL. Our highly skilled team of biochemistry experts believes in quality results and uses proprietary industry-leading, label-free SAMDI (Self-Assembled Monolayer Desorption Ionization) technology to deliver decision-making data for diverse targets and analytes. SAMDI Tech offers label-free drug discovery solutions for better, faster results. The company was founded by Michael Scholle, Milan Mrksich. Emilio Cordova has been the CEO of the company since 2015. SAMDI Tech was acquired by Charles River Laboratories International, Inc. on January 30, 2023 for $50 million. | Health Technology |
- Börse
- Insiders
- Emilio Cordova
- Erfahrung
